SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Quantitative super-resolution imaging of platelet degranulation reveals differential release of von Willebrand factor and von Willebrand factor propeptide from alpha-granules.

Swinkels, M; Hordijk, S; Bürgisser, PE; Slotman, JA; Carter, T; Leebeek, FWG; Jansen, AJG; Voorberg, J; Bierings, R (2023) Quantitative super-resolution imaging of platelet degranulation reveals differential release of von Willebrand factor and von Willebrand factor propeptide from alpha-granules. J Thromb Haemost, 21 (7). pp. 1967-1980. ISSN 1538-7836 https://doi.org/10.1016/j.jtha.2023.03.041
SGUL Authors: Carter, Thomas David

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview
[img] Microsoft Word (.docx) (Supplementary Material) Published Version
Available under License Creative Commons Attribution.

Download (9MB)
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (4MB) | Preview

Abstract

BACKGROUND: Von Willebrand factor (VWF) and VWF propeptide (VWFpp) are stored in eccentric nanodomains within platelet alpha-granules. VWF and VWFpp can undergo differential secretion following Weibel-Palade body exocytosis in endothelial cells; however, it is unclear if the same process occurs during platelet alpha-granule exocytosis. Using a high-throughput 3-dimensional super-resolution imaging workflow for quantification of individual platelet alpha-granule cargo, we studied alpha-granule cargo release in response to different physiological stimuli. OBJECTIVES: To investigate how VWF and VWFpp are released from alpha-granules in response to physiological stimuli. METHODS: Platelets were activated with protease-activated receptor 1 (PAR-1) activating peptide (PAR-1 ap) or collagen-related peptide (CRP-XL). Alpha-tubulin, VWF, VWFpp, secreted protein acidic and cysteine rich (SPARC), and fibrinogen were imaged using 3-dimensional structured illumination microscopy, followed by semiautomated analysis in FIJI. Uptake of anti-VWF nanobody during degranulation was used to identify alpha-granules that partially released content. RESULTS: VWFpp overlapped with VWF in eccentric alpha-granule subdomains in resting platelets and showed a higher degree of overlap with VWF than SPARC or fibrinogen. Activation of PAR-1 (0.6-20 μM PAR-1 ap) or glycoprotein VI (GPVI) (0.25-1 μg/mL CRP-XL) signaling pathways caused a dose-dependent increase in alpha-granule exocytosis. More than 80% of alpha-granules remained positive for VWF, even at the highest agonist concentrations. In contrast, the residual fraction of alpha-granules containing VWFpp decreased in a dose-dependent manner to 23%, whereas SPARC and fibrinogen were detected in 60% to 70% of alpha-granules when stimulated with 20 μM PAR-1 ap. Similar results were obtained using CRP-XL. Using an extracellular anti-VWF nanobody, we identified VWF in postexocytotic alpha-granules. CONCLUSION: We provide evidence for differential secretion of VWF and VWFpp from individual alpha-granules.

Item Type: Article
Additional Information: © 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: blood platelets, exocytosis, hemostasis, secretory vesicles, von Willebrand factor, Humans, von Willebrand Factor, Endothelial Cells, Weibel-Palade Bodies, Blood Platelets, Fibrinogen, Exocytosis, Blood Platelets, Weibel-Palade Bodies, Endothelial Cells, Humans, Fibrinogen, von Willebrand Factor, Exocytosis, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: J Thromb Haemost
ISSN: 1538-7836
Language: eng
Dates:
DateEvent
15 June 2023Published
13 April 2023Published Online
31 March 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
LSBR-1707Landsteiner Stichting voor Bloedtransfusie ResearchUNSPECIFIED
LSBR-2005Landsteiner Stichting voor Bloedtransfusie ResearchUNSPECIFIED
PubMed ID: 37061132
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115294
Publisher's version: https://doi.org/10.1016/j.jtha.2023.03.041

Actions (login required)

Edit Item Edit Item